SHARE
COPY LINK

VACCINE

Norway presents revised Covid-19 vaccination plan

The Norwegian Institute of Public Health (NIPH) has updated its roadmap for the country’s vaccination programme. The authority expects all adults over the age of 18 to have received their first dose by mid-July.

Norway presents revised Covid-19 vaccination plan
(Photo by STR / AFP)

Previously, the NIPH best case scenario aimed to have offered everybody their first dose of the vaccine by the end of June.

“There are small differences in this vaccination scenario compared to what we (previously) presented on March 12th. The updated scenario shows that there will be approximately a couple of weeks of delay, both for when the age group 45-55 receive their first dose, and when those over 18 have been vaccinated”, NIPH director of infection control Geir Bukholm said in a statement.

The Norwegian health authority also plans to use the single-dose Janssen vaccine from Johnson & Johnson to help vaccinate people between the ages of 18 and 44.

“For many in the age group from 18 to 44, this (the first dose) will probably also be the last dose, because we plan to use the Janssen vaccine from Johnson & Johnson on this group,” Bukholm told national broadcaster NRK.

The NIPH conservative vaccine schedule. Screenshot: NIPH

Last week, Johnson & Johnson announced that they could deliver 52,000 doses in April, far less than the 310,000 doses the NIPH had estimated that Norway would receive during the month. Bukholm is nevertheless confident that the vaccines will be delivered.

“We have no evidence that the vaccine will not be delivered as agreed. In the first scenarios we posted, we did not have an agreement on exact delivery dates. We have that now,” he said.

READ NORE: Norwegian prime minister hopes to reopen most of the country by September 

The AstraZeneca vaccine, which has had its use in Norway suspended while links to serious suspected side effects are investigated, is still included in the plan.

The new plan stipulates that the break will last for five weeks. If there are further delays or the NIPH decides to drop the vaccine, that will delay the rest of the program.

In the revised roadmap, health authorities are planning to use the four vaccines that have already been approved. These are the Moderna, Pfizer, Johnson & Johnson and AstraZeneca vaccines. If more are approved, the plan could be sped up.

Many people will be vaccinated during the summer holidays under the current schedule. Last week, NRK reported that several municipalities had to cancel vaccination over the Easter period as so many had refused the vaccine due to it being the holidays.

Bukholm hopes to avoid similar postponements in the summer.

“We hope that people accept the vaccination slot they are offered. Especially during the summer holidays when we are nearing the end of the vaccination programme,” he said.

To date more than 620,000, or around one-in-ten, people In Norway have been vaccinated. The vaccine will be free and accessible to everyone in Norway, including foreign nationals who reside in the country.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS